Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Apr
9
2020
“Method of Preparation” Claims Found Patent-Eligible Under §101 McDermott Will & Emery
Aug
13
2020
“Method of Preparation” Claims Still Patent Eligible Under § 101 in Modified Opinion McDermott Will & Emery
Feb
24
2022
“Negative” Patent Claim Limitations—May They be Adequately Described by Omission? Proskauer Rose LLP
May
14
2020
“Non-Limiting” Prior Art Claims Support Obviousness After Standing Is Established McDermott Will & Emery
Jan
4
2015
“Nonce” Words and Means-Plus-Function Analysis McDermott Will & Emery
Feb
1
2023
“Not My Work”: When Artists Dispute Authorship Sheppard, Mullin, Richter & Hampton LLP
Apr
2
2020
“Numerous Reasons” Support Finding Inequitable Conduct: Another Example of the Federal Circuit’s Current Approach to Inequitable Conduct Squire Patton Boggs (US) LLP
Jun
28
2012
“Obamacare” Survives – Including Path to Generic Biologicals Schwegman, Lundberg & Woessner, P.A.
Dec
7
2011
“One,” But Not the One and Only McDermott Will & Emery
Dec
9
2012
“PARIS” Is Misdescriptive of Goods Designed in Miami and Manufactured in Asia McDermott Will & Emery
Jun
30
2011
“Particular Machine” not required: Ex Parte Dietz et al., Appeal 2009-008029, BPAI Schwegman, Lundberg & Woessner, P.A.
Sep
20
2013
“Patent Assertion and Startup Innovation": Some Sensible Ideas Schwegman, Lundberg & Woessner, P.A.
Feb
18
2015
“Precision Medicine” Initiative Leaves Patents “Lost in Space” Schwegman, Lundberg & Woessner, P.A.
Sep
29
2016
“Processing System” Does Not Render Claims Indefinite Mintz
Aug
30
2016
“Providing . . . Information” to Medical Providers Is Not Given Patentable Weight McDermott Will & Emery
Nov
2
2015
“Raging Bull” and the Patent Act: Laches Still Available in Patent Cases - SCA Hygiene Products v. First Quality Baby Products McDermott Will & Emery
Jun
18
2014
“REDSKINS” US Trademark Registrations are Canceled for Disparaging Native Americans Mintz
Oct
29
2014
“Removed” Versus “Removable” Controls Infringement Inquiry McDermott Will & Emery
May
19
2015
“Restriction Requirements” Series, Part 1: Considering Restrictions When Developing A Claim Filing Strategy Mintz
Aug
1
2013
“Reverse Payment” Settlements Face Greater Antitrust Scrutiny Following U.S. Supreme Court Ruling in FTC v. Actavis McDermott Will & Emery
Jun
21
2013
“Reverse Payment” Settlements Subject to Greater Antitrust Scrutiny: Implications of Supreme Court FTC v. Actavis Ruling McDermott Will & Emery
Jul
26
2017
“Ruff” Start for Defendant in Pet Ramp Patent Dispute Proskauer Rose LLP
Jul
30
2020
“Salacious” Content Doesn’t Bar Discovery in Copyright Infringement Suit McDermott Will & Emery
Jul
8
2020
“Seams” Like Activity Giving Rise to Infringement Risk Supports Appellate Jurisdiction McDermott Will & Emery
Jun
9
2022
“Self-Similar” More Objective Than One Might Think McDermott Will & Emery
Aug
5
2021
“Shall Be” Language May Not Effectuate a Present Automatic Assignment of Rights Finnegan
Sep
8
2017
“Share And Share Alike”: UK IPO Publishes Report On The Challenges Of Social Media And Online IP Infringement Squire Patton Boggs (US) LLP
Jan
18
2022
“Show More of You”: Amgen v. Sandoz, Battling it Out on Amgen’s Otezla® Drug Finnegan
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins